<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
	>
<channel>
	<title>Comments on: Perspective on the FDA Social Media Hearing</title>
	<atom:link href="http://blog.wcgworld.com/index.php/2009/11/perspective-on-the-fda-social-media-hearing/feed" rel="self" type="application/rss+xml" />
	<link>http://blog.wcgworld.com/2009/11/perspective-on-the-fda-social-media-hearing</link>
	<description>For Today&#039;s Company</description>
	<lastBuildDate>Sat, 04 Feb 2012 03:45:00 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
	<item>
		<title>By: A conversation about pharma and social media &#124; NevilleHobson.com</title>
		<link>http://blog.wcgworld.com/2009/11/perspective-on-the-fda-social-media-hearing/comment-page-1#comment-125</link>
		<dc:creator>A conversation about pharma and social media &#124; NevilleHobson.com</dc:creator>
		<pubDate>Mon, 22 Mar 2010 09:11:13 +0000</pubDate>
		<guid isPermaLink="false">http://blog.wcgworld.com/?p=11#comment-125</guid>
		<description>[...] media as a legitimate communication tool in a highly-regulated industry. That culminated in the public hearing by industry regulator the FDA last November into “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools,” [...]</description>
		<content:encoded><![CDATA[<p>[...] media as a legitimate communication tool in a highly-regulated industry. That culminated in the public hearing by industry regulator the FDA last November into “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools,” [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: WCG ThoughtLeader Interview &#8211; Len Starnes, Bayer Schering Pharma &#124; Common Sense</title>
		<link>http://blog.wcgworld.com/2009/11/perspective-on-the-fda-social-media-hearing/comment-page-1#comment-124</link>
		<dc:creator>WCG ThoughtLeader Interview &#8211; Len Starnes, Bayer Schering Pharma &#124; Common Sense</dc:creator>
		<pubDate>Mon, 22 Mar 2010 08:14:44 +0000</pubDate>
		<guid isPermaLink="false">http://blog.wcgworld.com/?p=11#comment-124</guid>
		<description>[...] social media communication and trends in Europe for pharma companies, the regulatory environment, FDA guidelines and what’s needed in [...]</description>
		<content:encoded><![CDATA[<p>[...] social media communication and trends in Europe for pharma companies, the regulatory environment, FDA guidelines and what’s needed in [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

